title: Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury.
abstract: The blood-spinal cord barrier (BSCB) is a specialized protective barrier that regulates the movement of molecules between blood vessels and the spinal cord parenchyma. Analogous to the blood-brain barrier (BBB), the BSCB plays a crucial role in maintaining the homeostasis and internal environmental stability of the central nervous system (CNS). After spinal cord injury (SCI), BSCB disruption leads to inflammatory cell invasion such as neutrophils and macrophages, contributing to permanent neurological disability. In this review, we focus on the major proteins mediating the BSCB disruption or BSCB repair after SCI. This review is composed of three parts. Section 1. SCI and the BSCB of the review describes critical events involved in the pathophysiology of SCI and their correlation with BSCB integrity/disruption. Section 2. Major proteins involved in BSCB disruption in SCI focuses on the actions of matrix metalloproteinases (MMPs), tumor necrosis factor alpha (TNF-α), heme oxygenase-1 (HO-1), angiopoietins (Angs), bradykinin, nitric oxide (NO), and endothelins (ETs) in BSCB disruption and repair. Section 3. Therapeutic approaches discusses the major therapeutic compounds utilized to date for the prevention of BSCB disruption in animal model of SCI through modulation of several proteins.
authors.affiliation: Department of Neurosurgery, CHA University, CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, 13496, Republic of Korea.
authors.forename: Hemant
authors.initials: H
authors.lastname: Kumar
authors.affiliation: Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA.
authors.forename: Alexander E
authors.initials: AE
authors.lastname: Ropper
authors.affiliation: Department of Biomedical Science, CHA University, Seongnam-si, Gyeonggi-do, 13488, Republic of Korea. soohong@cha.ac.kr.
authors.forename: Soo-Hong
authors.initials: SH
authors.lastname: Lee
authors.affiliation: Department of Neurosurgery, CHA University, CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, 13496, Republic of Korea. hanib@cha.ac.kr.
authors.forename: Inbo
authors.initials: I
authors.lastname: Han
mesh_terms: D000818:Animals; D008954:Models, Biological; D011506:Proteins / Q000378:metabolism; D013116:Spinal Cord / Q000473:pathology*; D013119:Spinal Cord Injuries / Q000097:blood* / Q000473:pathology / Q000628:therapy*
chemical_list: D011506:Proteins
keywords: Angiopoietins; Blood-spinal cord barrier; Bradykinin; HO-1; Matrix metalloproteinase; Spinal cord injury; TNF-α